Select human cancer mutants of NRMT1 alter its catalytic activity and decrease N-terminal trimethylation.

MLA

Shields, Kaitlyn M., et al. “Select Human Cancer Mutants of NRMT1 Alter Its Catalytic Activity and Decrease N-Terminal Trimethylation.” Protein Science : A Publication of the Protein Society, vol. 26, no. 8, Aug. 2017, pp. 1639–52. EBSCOhost, https://doi.org/10.1002/pro.3202.

APA

Shields, K. M., Tooley, J. G., Petkowski, J. J., Wilkey, D. W., Garbett, N. C., Merchant, M. L., Cheng, A., & Schaner Tooley, C. E. (2017). Select human cancer mutants of NRMT1 alter its catalytic activity and decrease N-terminal trimethylation. Protein Science : A Publication of the Protein Society, 26(8), 1639–1652. https://doi.org/10.1002/pro.3202

Chicago

Shields, Kaitlyn M, John G Tooley, Janusz J Petkowski, Daniel W Wilkey, Nichola C Garbett, Michael L Merchant, Alan Cheng, and Christine E Schaner Tooley. 2017. “Select Human Cancer Mutants of NRMT1 Alter Its Catalytic Activity and Decrease N-Terminal Trimethylation.” Protein Science : A Publication of the Protein Society 26 (8): 1639–52. doi:10.1002/pro.3202.